trapidil has been researched along with thymidine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fahr, A; Giessler, C; Kudryashov, SA; Mest, HJ; Orekhov, AN; Smirnov, VN; Tertov, VV | 1 |
| Awazu, M; Fujita, H; Hida, M; Ishikura, K | 1 |
2 other study(ies) available for trapidil and thymidine
| Article | Year |
|---|---|
Trapidil derivatives as potential antiatherosclerotic drugs.
Topics: Arteriosclerosis; Cholesterol; Cholesterol Esters; Collagen; Humans; In Vitro Techniques; Lipid Metabolism; Middle Aged; Phospholipids; Phosphoric Diester Hydrolases; Pyrimidines; Thromboxanes; Thymidine; Trapidil; Triglycerides | 1987 |
Trapidil inhibits platelet-derived growth factor-induced migration via protein kinase A and RhoA/Rho-associated kinase in rat vascular smooth muscle cells.
Topics: Amides; Animals; Cell Movement; Cells, Cultured; Colforsin; Cyclic AMP-Dependent Protein Kinases; Enzyme Activation; Enzymes; Humans; Immunoblotting; Intracellular Signaling Peptides and Proteins; Isoquinolines; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Protein Serine-Threonine Kinases; Pyridines; Rats; rho-Associated Kinases; rhoA GTP-Binding Protein; Sulfonamides; Thymidine; Trapidil; Tritium | 2005 |